SCHEMBL6664479

SCHEMBL6664479

CN1C(=O)C(Cc2ccc(F)c(Cl)c2)C(=O)c2cc(C(=O)O)ccc21.NC(=O)c1ccncc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 5/20 0.40
KDM5A P29375 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
ROCK1 Q13464 1/20 0.36
PRKAG1 P54619 1/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAB1 Q9Y478 1/20 0.34
CCKAR P32238 3/20 0.33
CCKBR P32239 3/20 0.33
PTGER4 P35408 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NR1H2 P55055 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6669268 0.93 ROCK2 (0.38) ROCK2KDM5AKDM5BPSEN1PSEN2
SCHEMBL6664689 0.92 PSEN1 (0.43) ROCK2KDM5AKDM5BPSEN1PSEN2
SCHEMBL6663962 0.90 ROCK2 (0.46) ROCK2PSEN1PSEN2APH1BNCSTN
SCHEMBL6681227 0.90 PRKAG1 (0.39) ROCK2KDM5AKDM5BPRKAG1PRKAA2
SCHEMBL6665597 0.88 ROCK2 (0.41) ROCK2KDM5AKDM5BROCK1NR1H2
SCHEMBL6662371 0.86 MAOB (0.38) ROCK2KDM5AKDM5BPSEN1PSEN2
SCHEMBL6667909 0.86 NNMT (0.40) KDM5AKDM5BPSEN1PSEN2APH1B
SCHEMBL6685279 0.83 NR1H2 (0.38) ROCK2KDM5AKDM5BCCKARCCKBR
Niacinamide SCHEMBL6669309 0.82 PSEN1 (0.41) ROCK2PSEN1PSEN2APH1BNCSTN
SCHEMBL6680077 0.81 NR1H2 (0.40) KDM5AKDM5BPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014388-A1 6,6-FUSED HETEROARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed